AstraZeneca Pharma India board to consider financial results

27 Jul 2012 Evaluate
AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on August 10, 2012, to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Astrazeneca Pharma I Share Price

6359.65 70.75 (1.12%)
22-Nov-2024 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.80
Dr. Reddys Lab 1201.05
Cipla 1479.10
Lupin 2044.90
Zydus Lifesciences 940.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.